Global Non Steroidal Anti Inflammatory Drugs Market Overview
Anti-inflammatory medications are prescribed to treat disorders such as asthma, arthritis, chronic obstructive pulmonary disorder (COPD), and others. The rising prevalence of these diseases is the primary driver of market growth. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat pain and inflammation. These have become the most widely used medicines around the world as the number of prescriptions has increased. Because of three essential properties: analgesic, antipyretic, and anti-inflammatory, these are considered the first line of treatment in pain management. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used to treat pain since the 1960s and 1970s when the FDA approved the first few main molecules including diclofenac and ibuprofen. The Non-Steroidal Anti-Inflammatory Drugs Market accounted for US$ 16.4 billion in 2020 and is estimated to be US$ 28.7 billion by 2030 and is anticipated to register a CAGR of 6.0%.
Impact of Covid-19 pandemic on market
The COVID-19 outbreak has brought the entire world to a halt. Rising government and corporate funding could aid in the battle against this highly contagious disease. The pandemic is expected to have an effect on almost every industry. Chronic pain has a significant health and economic impact due to lost efficiency and medication costs.
Global Non Steroidal Anti Inflammatory Drugs Market Dynamics
Rising initiatives by government bodies
Inflammation and pain-causing conditions are becoming more common every day across the world. It is increasing the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to cure and treat chronic and acute pain. Diclofenac and ibuprofen are the most widely prescribed pain relievers. Several countries' governments are taking steps to reduce the cost of diagnosing and treating chronic pain. NSAIDs, on the other hand, can cause a variety of side effects, including dizziness, stomach aches, ulcers, and allergic reactions. It has the potential to stifle business expansion.
Growth in business operations by emerging and small sized players
The global demand for non-steroidal anti-inflammatory drugs is expected to expand rapidly in the coming years, owing to significant investments in product R&D. One of the major factors driving the growth of the non-steroidal anti-inflammatory drugs market is the rising prevalence of pain and inflammation-causing diseases. The use of these medications to treat acute and chronic pain is increasing. The increasing prevalence of bone and joint disorders such as rheumatoid arthritis and osteoarthritis, as well as a rise in the number of hospital operations, are expected to drive the bone and joint pain segment. The demand for non-steroidal anti-inflammatory drugs is expected to rise due to rising prevalence of pain disorders, an increase in the geriatric population at high risk of various diseases, the acceptance of pain management therapeutics by end-users, and favorable regulatory and health-care reforms.
Global Non Steroidal Anti Inflammatory Drugs Market Segmentation
Source: Prophecy Market Insights
The non Steroidal anti-inflammatory drugs market is segmented based on type, disease indication, route of administration, application, and region.
On the basis of type, the non steroidal anti-inflammatory drugs market is segmented into paracetamol, Ibuprofen, Aspirin, naproxen and others. Based on disease indication, the target market is segmented into arthritis, migraine, ophthalmic and others. On the basis of route of administration, the market is segmented into oral and parenteral. On the basis of application, the target market is segmented into hospital pharmacy, retail pharmacy and online pharmacy.
Regional Insights:
On region the non Steroidal anti-inflammatory drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe, on the other hand, is projected to rise steadily, owing to favorable health reimbursement policies, a higher prevalence of migraine, and active government support. The rising use of over-the-counter NSAIDs and the growing geriatric population in Asia Pacific are expected to boost growth.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Type- paracetamol, Ibuprofen, aspirin, Naproxen and others By disease indication– Arthritis, Migraine, Ophthalmic and others By route of administration- Oral and Parenteral By Application– hospital pharmacy, retail pharmacy and online pharmacy |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For the purpose of this study, has segmented the non-steroidal anti-inflammatory drugs market report based on type, disease indication, route of administration, application, and region.
Non Steroidal Anti-inflammatory drugs Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Non Steroidal Anti Inflammatory Drugs Market Key Players
The key players operating in the non steroidal anti-inflammatory drugs market include GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Pfizer Inc., Boehringer Ingelheim International GmbH, AstraZeneca, Bayer AG, Horizon Therapeutics plc, Zyla Life Sciences and other key players. GSK accounted for the largest share of the demand for non-steroidal anti-inflammatory drugs (NSAIDs). As several new players strive to enter the market through new product releases and strategic alliances, competition in the market is steadily growing.
Global Non Steroidal Anti Inflammatory Drugs Market Company Profile
- GlaxoSmithKline plc,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Johnson a d Johnson services
- Pfizer Inc.
- Boehringer Ingelheim International GmbH,
- AstraZeneca
- Bayer AG
- Horizon Therapeutics plc
- Zyla Life Sciences
- Others
“*” marked represents similar segmentation in other categories in the respective section
Global Non Steroidal Anti Inflammatory Drugs Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Non Steroidal Anti-Inflammatory drugs Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By disease Indication
- Market Snippet, By route of administration
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Non Steroidal Anti-Inflammatory drugs Market, By Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Paracetamol
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Ibuprofen
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Aspirin
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Naproxen
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Non Steroidal Anti-Inflammatory drugs Market, By disease Indication , 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Arthritis
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Migraine
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Ophthalmic
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Non Steroidal Anti-Inflammatory drugs Market, By route of distribution, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Oral
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Parenteral
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Non steroidal Anti-Inflammatory Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital pharmacy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Retail pharmacy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Online pharmacy
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Non Steroidal Anti-Inflammatory drugs Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- GlaxoSmithKline plc,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Johnson a d Johnson services
- Pfizer Inc.
- Boehringer Ingelheim International GmbH,
- AstraZeneca
- Bayer AG
- Horizon Therapeutics plc
- Zyla Life Sciences
- Others
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The non steroidal anti-inflammatory drugs market is segmented based on type, disease indication, route of administration, application, and region.
One of the major factors driving the growth of the non-steroidal anti-inflammatory drugs market is the rising prevalence of pain and inflammation-causing diseases.
Europe, on the other hand, is projected to rise steadily, owing to favorable health reimbursement policies, a higher prevalence of migraine, and active government support.
GSK accounted for the largest share of the demand for non-steroidal anti-inflammatory drugs (NSAIDs). As several new players strive to enter the market through new product releases and strategic alliances, competition in the market is steadily growing.